Stock Report

3B BlackBio receives Export Order for CE-IVD TRUPCR® UTI ID Panel Kit and TRUPCR® UTI AST Panel Kit

Posted On : 2022-08-18 14:29:28( TIMEZONE : IST )

3B BlackBio receives Export Order for CE-IVD TRUPCR® UTI ID Panel Kit and TRUPCR® UTI AST Panel Kit

After extensive R&D efforts, the subsidiary company M/s. 3B BlackBio Biotech India Limited has got an export order valued at INR Twenty Million (₹ 20 Million) for the recently launched CE-IVD TRUPCR® UTI ID Panel Kit and TRUPCR® UTI AST Panel Kit. This RT-PCR based multiplex panel allows the detection and differentiation of 14 pathogens that cause urinary tract infections (UTI), as well as 14 antimicrobial resistance (AMR) genes encoding resistance to 5 class of antibiotics in one single run directly from native urine samples within 5 hours. This assay will not only help in early diagnosis of patient infection but will also help the clinicians to judiciously select the most effective antibiotic class for treatment which can reduce spread and rise of antibiotic resistance.

Due to confidentiality reasons the customer details and terms of the transactions are not being disclosed. This export order will pave way for bigger opportunities as it bestows the trust of its customers.

The TRUPCR® range offers one of the largest portfolio of infectious diseases and AMR assays on the market which includes Comprehensive Respiratory Pathogen Detection Panel, VRE Detection, Carbapenem Resistance Detection, MRSA Detection and many more. The range is led by the vision of the company to offer innovative diagnostic solutions to enhance laboratory efficiency and ultimately resulting in better patient care and treatment.

The TRUPCR® products are also offered through 3B BlackBio Biotech India's European Subsidiary, TRUPCR Europe Ltd, based in Manchester, UK. The European subsidiary offers direct tech support, sales and logistics for European customers.

Mr. Dhirendra Dubey, CEO stated 'I am delighted by this order which shows laboratories recognize the TRUPCR® kits to be unique in performance and design over competitor assays. This order is in line with the growth to become a leading global player in the molecular diagnostic market'.

Shares of KILPEST INDIA LTD. was last trading in BSE at Rs. 380.15 as compared to the previous close of Rs. 365.35. The total number of shares traded during the day was 11096 in over 403 trades.

The stock hit an intraday high of Rs. 383.00 and intraday low of 353.25. The net turnover during the day was Rs. 4069991.00.

Source : Equity Bulls


KILPESTINDIA INE994E01018 3BBlackBioBiotech ExportOrder OrderWin